Tyramine infusions and selective monoamine oxidase inhibitor treatment - I. Changes in pressor sensitivity

David Pickar, Robert M. Cohen, David C. Jimerson, Dennis L. Murphy

Research output: Contribution to journalArticle

Abstract

The enhanced sensitivity to the pressor effects of tyramine, an indirect-acting sympathomimetic found abundantly in the diet, is a well-known potentially dangerous side effect occurring during treatment with commonly used nonselective monoamine oxidase (MAO) inhibitors. The effects of treatment with the selective MAO-A inhibitor clorgyline and the partially selective MAO-B inhibitors pargyline and deprenyl on tyramine's pressor effects were studied in depressed patients using an IV steady-state tyramine infusion technique. After 4 weeks of treatment, clorgyline produced a significantly greater increase in tyramine sensitivity in comparison to a medication-free baseline (29-fold) than did pargyline (12-fold) or deprenyl (1.7-fold). The pressor effects of tyramine were significantly prolonged after cessation of infusion during both clorgyline and pargyline, but not deprenyl treatment. These data from IV tyramine administrations suggest that intestinal MAO inhibition is not the major determinant of the enhanced tyramine pressor sensitivity produced by clorgyline and pargyline.

Original languageEnglish (US)
Pages (from-to)4-7
Number of pages4
JournalPsychopharmacology
Volume74
Issue number1
DOIs
StatePublished - Jun 1981
Externally publishedYes

Fingerprint

Tyramine
Monoamine Oxidase Inhibitors
Clorgyline
Pargyline
Selegiline
Monoamine Oxidase
Therapeutics
Sympathomimetics
Diet

Keywords

  • Pressor sensitivity
  • Selective MAO-A and MAO-B inhibitors
  • Tyramine

ASJC Scopus subject areas

  • Pharmacology

Cite this

Tyramine infusions and selective monoamine oxidase inhibitor treatment - I. Changes in pressor sensitivity. / Pickar, David; Cohen, Robert M.; Jimerson, David C.; Murphy, Dennis L.

In: Psychopharmacology, Vol. 74, No. 1, 06.1981, p. 4-7.

Research output: Contribution to journalArticle

Pickar, David ; Cohen, Robert M. ; Jimerson, David C. ; Murphy, Dennis L. / Tyramine infusions and selective monoamine oxidase inhibitor treatment - I. Changes in pressor sensitivity. In: Psychopharmacology. 1981 ; Vol. 74, No. 1. pp. 4-7.
@article{f8f7bf611b4443b1bd3f5ff7715e0c1d,
title = "Tyramine infusions and selective monoamine oxidase inhibitor treatment - I. Changes in pressor sensitivity",
abstract = "The enhanced sensitivity to the pressor effects of tyramine, an indirect-acting sympathomimetic found abundantly in the diet, is a well-known potentially dangerous side effect occurring during treatment with commonly used nonselective monoamine oxidase (MAO) inhibitors. The effects of treatment with the selective MAO-A inhibitor clorgyline and the partially selective MAO-B inhibitors pargyline and deprenyl on tyramine's pressor effects were studied in depressed patients using an IV steady-state tyramine infusion technique. After 4 weeks of treatment, clorgyline produced a significantly greater increase in tyramine sensitivity in comparison to a medication-free baseline (29-fold) than did pargyline (12-fold) or deprenyl (1.7-fold). The pressor effects of tyramine were significantly prolonged after cessation of infusion during both clorgyline and pargyline, but not deprenyl treatment. These data from IV tyramine administrations suggest that intestinal MAO inhibition is not the major determinant of the enhanced tyramine pressor sensitivity produced by clorgyline and pargyline.",
keywords = "Pressor sensitivity, Selective MAO-A and MAO-B inhibitors, Tyramine",
author = "David Pickar and Cohen, {Robert M.} and Jimerson, {David C.} and Murphy, {Dennis L.}",
year = "1981",
month = "6",
doi = "10.1007/BF00431747",
language = "English (US)",
volume = "74",
pages = "4--7",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Tyramine infusions and selective monoamine oxidase inhibitor treatment - I. Changes in pressor sensitivity

AU - Pickar, David

AU - Cohen, Robert M.

AU - Jimerson, David C.

AU - Murphy, Dennis L.

PY - 1981/6

Y1 - 1981/6

N2 - The enhanced sensitivity to the pressor effects of tyramine, an indirect-acting sympathomimetic found abundantly in the diet, is a well-known potentially dangerous side effect occurring during treatment with commonly used nonselective monoamine oxidase (MAO) inhibitors. The effects of treatment with the selective MAO-A inhibitor clorgyline and the partially selective MAO-B inhibitors pargyline and deprenyl on tyramine's pressor effects were studied in depressed patients using an IV steady-state tyramine infusion technique. After 4 weeks of treatment, clorgyline produced a significantly greater increase in tyramine sensitivity in comparison to a medication-free baseline (29-fold) than did pargyline (12-fold) or deprenyl (1.7-fold). The pressor effects of tyramine were significantly prolonged after cessation of infusion during both clorgyline and pargyline, but not deprenyl treatment. These data from IV tyramine administrations suggest that intestinal MAO inhibition is not the major determinant of the enhanced tyramine pressor sensitivity produced by clorgyline and pargyline.

AB - The enhanced sensitivity to the pressor effects of tyramine, an indirect-acting sympathomimetic found abundantly in the diet, is a well-known potentially dangerous side effect occurring during treatment with commonly used nonselective monoamine oxidase (MAO) inhibitors. The effects of treatment with the selective MAO-A inhibitor clorgyline and the partially selective MAO-B inhibitors pargyline and deprenyl on tyramine's pressor effects were studied in depressed patients using an IV steady-state tyramine infusion technique. After 4 weeks of treatment, clorgyline produced a significantly greater increase in tyramine sensitivity in comparison to a medication-free baseline (29-fold) than did pargyline (12-fold) or deprenyl (1.7-fold). The pressor effects of tyramine were significantly prolonged after cessation of infusion during both clorgyline and pargyline, but not deprenyl treatment. These data from IV tyramine administrations suggest that intestinal MAO inhibition is not the major determinant of the enhanced tyramine pressor sensitivity produced by clorgyline and pargyline.

KW - Pressor sensitivity

KW - Selective MAO-A and MAO-B inhibitors

KW - Tyramine

UR - http://www.scopus.com/inward/record.url?scp=0019460958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019460958&partnerID=8YFLogxK

U2 - 10.1007/BF00431747

DO - 10.1007/BF00431747

M3 - Article

C2 - 6791202

AN - SCOPUS:0019460958

VL - 74

SP - 4

EP - 7

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 1

ER -